Rodent genetic models of Huntington disease

被引:116
|
作者
Heng, Mary Y. [1 ,2 ]
Detloff, Peter J. [3 ]
Albin, Roger L. [1 ,2 ,4 ]
机构
[1] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 36294 USA
[4] VAAAHS, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA
关键词
polyglutamine; mouse; striatum;
D O I
10.1016/j.nbd.2008.06.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington disease (HD) is a dominantly inherited human neurodegenerative disorder characterized by motor deficits, cognitive impairment, and psychiatric symptoms leading to inexorable decline and death. Since the identification of the huntingtin gene and the characteristic expanded CAG repeat/polyglutamine mutation, multiple murine genetic models and one rat genetic model have been generated. These models fall into two general categories: transgenic models with ectopic expression of the characteristic expanded CAG codon mutation, and knock-in models with expression of mutant huntingtin under control of endogenous regulatory elements. Rodent genetic models are valuable tools for studying mechanisms of pathogenesis in HD and for preclinical evaluation of possible therapies. In this mini-review, we provide a concise comparative summary of rodent genetic models of HD. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease
    Emerich, DF
    Cain, CK
    Greco, C
    Saydoff, JA
    Hu, ZY
    Liu, HJ
    Lindner, MD
    CELL TRANSPLANTATION, 1997, 6 (03) : 249 - 266
  • [32] Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a transgenic rodent model for Huntington Disease
    Adjeroud, Najia
    Yaguee, Sara
    Yu-Taeger, Libo
    Bozon, Bruno
    Leblanc-Veyrac, Pascale
    Riess, Olaf
    Allain, Philippe
    Nguyen, Huu Phuc
    Doyere, Valerie
    El Massioui, Nicole
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2015, 125 : 249 - 257
  • [33] Animal Models of Huntington's Disease for Translation to the Clinic: Best Practices
    Menalled, Liliana
    Brunner, Daniela
    MOVEMENT DISORDERS, 2014, 29 (11) : 1375 - 1390
  • [34] Human cellular models of medium spiny neuron development and Huntington disease
    Golas, Monika M.
    LIFE SCIENCES, 2018, 209 : 179 - 196
  • [35] Cognitive Deficits in Huntington's Disease: Insights from Animal Models
    Wang, Elizabeth A.
    Cepeda, Carlos
    Levine, Michael S.
    CURRENT GERIATRICS REPORTS, 2012, 1 (01): : 29 - 38
  • [36] Cognitive Deficits in Huntington’s Disease: Insights from Animal Models
    Elizabeth A. Wang
    Carlos Cepeda
    Michael S. Levine
    Current Translational Geriatrics and Experimental Gerontology Reports, 2012, 1 (1): : 29 - 38
  • [37] Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease
    Menalled, L
    Zanjani, H
    MacKenzie, L
    Koppel, A
    Carpenter, E
    Zeitlin, S
    Chesselet, MF
    EXPERIMENTAL NEUROLOGY, 2000, 162 (02) : 328 - 342
  • [38] The Effect of Levosimendan on Two Distinct Rodent Models of Parkinson's Disease
    Abuirmaileh, Amjad N.
    Alzoubi, Karem H.
    Rababa'h, Abeer M.
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (11) : 1043 - 1051
  • [39] Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
    Imbriani, Paola
    Martella, Giuseppina
    Bonsi, Paola
    Pisani, Antonio
    NEUROBIOLOGY OF DISEASE, 2022, 173
  • [40] Training specificity, graft development and graft-mediated functional recovery in a rodent model of Huntington's disease
    Döbrössy, MD
    Dunnett, SB
    NEUROSCIENCE, 2005, 132 (03) : 543 - 552